X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-30 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $11.58 | +1,664 | 1,617,845 | 0% | +$19,269 | ||||||
| M | 2026-01-29 | ALMU | Aeluma, Inc. | Tompkins Mark N. | 10% | S - Sale | $16.15 | -95,000 | 1,824,988 | -5% | -$1,534,585 | |||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Swayze Eric | EVP Research | S - Sale | $82.93 | -6,179 | 48,065 | -11% | -$512,446 | ||||||
| D | 2026-02-02 | ALKS | Alkermes Plc. | Hopkinson Craig C. | EVP R, D, Chief Medical Office | S - Sale+OE | $33.93 | -9,000 | 57,740 | -13% | -$305,385 | |||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $83.45 | -6,179 | 69,702 | -8% | -$515,630 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | O'Neil Patrick R. | EVP CLO, GC | S - Sale | $83.53 | -6,179 | 71,983 | -8% | -$516,153 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Monia Brett P | CEO | S - Sale | $82.72 | -62,970 | 283,927 | -18% | -$5,208,979 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Hougen Elizabeth L | EVP, Finance, CFO | S - Sale | $83.24 | -6,988 | 132,881 | -5% | -$581,702 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Birchler Brian | EVP, Corp, Development Ops | S - Sale | $83.03 | -6,179 | 66,247 | -9% | -$513,048 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Bennett C Frank | EVP, Chief Scientific Officer | S - Sale | $82.95 | -5,885 | 100,293 | -6% | -$488,141 | ||||||
2026-01-30 | IONS | Ionis Pharmaceuticals Inc | Baroldi Joseph | EVP, Chief Business Officer | S - Sale | $82.96 | -5,296 | 50,185 | -10% | -$439,364 | ||||||
| D | 2026-02-02 | ALKS | Alkermes Plc. | Cooke Shane | Dir | S - Sale+OE | $34.57 | -61,200 | 103,744 | -37% | -$2,115,673 | |||||
2026-01-29 | SCHW | Schwab Charles Corp | Schwab Charles R. | Co-COB | S - Sale | $103.17 | -145,650 | 96,143,132 | 0% | -$15,025,968 | ||||||
| DM | 2026-01-30 | PUBM | Pubmatic, Inc. | Goel Rajeev K. | CEO, 10% | S - Sale+OE | $7.28 | -65,592 | 0 | -100% | -$477,251 | |||||
| D | 2026-02-02 | SLDB | Solid Biosciences Inc. | Tan Kevin | CFO, Treasurer | S - Sale+OE | $6.44 | -26,837 | 108,984 | -20% | -$172,747 | |||||
2026-01-30 | NXT | Nextpower Inc. | Watkins William D | Dir | S - Sale | $118.57 | -5,000 | 11,777 | -30% | -$592,850 | ||||||
| D | 2026-02-02 | SLDB | Solid Biosciences Inc. | Cumbo Alexander | Pres, CEO | S - Sale+OE | $6.44 | -80,258 | 270,931 | -23% | -$516,613 | |||||
| D | 2026-02-02 | SLDB | Solid Biosciences Inc. | Hanrahan Jessie | Chief Regulatory Officer | S - Sale+OE | $6.44 | -26,535 | 82,675 | -24% | -$170,803 | |||||
| D | 2026-02-02 | SLDB | Solid Biosciences Inc. | Brooks Gabriel | Chief Medical Officer | S - Sale+OE | $6.44 | -28,335 | 96,708 | -23% | -$182,390 | |||||
| D | 2026-02-02 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale+OE | $6.44 | -37,771 | 116,753 | -24% | -$243,128 | |||||
| D | 2026-02-02 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale+OE | $6.44 | -26,250 | 79,972 | -25% | -$168,969 | |||||
| D | 2026-01-29 | PLMR | Palomar Holdings, Inc. | Carter Timothy | Chief People Officer | S - Sale+OE | $122.04 | -254 | 2,244 | -10% | -$30,999 | |||||
| D | 2026-01-29 | PLMR | Palomar Holdings, Inc. | Herve Rodolphe | COO | S - Sale+OE | $122.04 | -425 | 4,921 | -8% | -$51,868 | |||||
| DM | 2025-01-29 | PLMR | Palomar Holdings, Inc. | Grant Angela L. | GC | S - Sale+OE | $121.97 | -1,022 | 12,275 | -8% | -$124,650 | |||||
| DM | 2025-01-29 | PLMR | Palomar Holdings, Inc. | Knutzen Jonathan | Chief Risk Officer | S - Sale+OE | $121.97 | -1,115 | 52,057 | -2% | -$135,991 | |||||
| DM | 2026-01-29 | PLMR | Palomar Holdings, Inc. | Armstrong Mac | CEO, COB | S - Sale+OE | $121.96 | -7,604 | 539,029 | -1% | -$927,355 | |||||
| DM | 2026-01-29 | PLMR | Palomar Holdings, Inc. | Uchida T Christopher | CFO | S - Sale+OE | $121.96 | -1,871 | 25,478 | -7% | -$228,180 | |||||
| DM | 2026-01-29 | PLMR | Palomar Holdings, Inc. | Christianson Jon | Pres | S - Sale+OE | $121.95 | -1,673 | 128,406 | -1% | -$204,026 | |||||
| M | 2024-12-30 | AIG | American International Group, Inc. | Walsh Keith | EVP, CFO | P - Purchase | $81.01 | +27 | 38,259 | 0% | +$2,207 | |||||
| DM | 2026-01-29 | YELP | Yelp Inc | Stoppelman Jeremy | CEO | S - Sale+OE | $27.38 | -90,000 | 756,458 | -11% | -$2,464,350 | |||||
| D | 2026-01-30 | SNX | Td Synnex Corp | Hume Richard T | Dir | S - Sale+OE | $160.41 | -492 | 47,515 | -1% | -$78,922 | |||||
2026-01-29 | SHCO | Soho House & Co Inc. | Popstefanov Gjorgi | Dir | P - Purchase | $9.00 | +11,111,111 | 11,111,111 | New | +$99,999,999 | ||||||
2026-02-02 | ABEO | Abeona Therapeutics Inc. | Wuchterl Donald A. | Dir | S - Sale | $5.09 | -14,814 | 167,935 | -8% | -$75,412 | ||||||
2026-02-02 | ABEO | Abeona Therapeutics Inc. | Crombez Eric | Dir | S - Sale | $5.09 | -16,284 | 63,456 | -20% | -$82,895 | ||||||
2026-01-29 | POWI | Power Integrations Inc | Balakrishnan Balu | Dir | S - Sale | $46.59 | -5,581 | 585,206 | -1% | -$260,036 | ||||||
2026-02-02 | KFS | Kingsway Financial Services Inc | Fitzgerald John Taylor Maloney | Pres, CEO | P - Purchase | $13.69 | +183 | 1,562,386 | 0% | +$2,505 | ||||||
2026-02-02 | KFS | Kingsway Financial Services Inc | Hansen Kent A | CFO, EVP | P - Purchase | $13.69 | +114 | 119,707 | 0% | +$1,561 | ||||||
2026-02-02 | VEL | Velocity Financial, Inc. | Taylor Jeffrey T. | EVP, Capital Markets | S - Sale | $20.33 | -1,772 | 181,115 | -1% | -$36,025 | ||||||
2026-02-02 | VEL | Velocity Financial, Inc. | Szczepaniak Mark R | CFO | S - Sale | $20.53 | -1,573 | 176,227 | -1% | -$32,292 | ||||||
| D | 2026-01-30 | PCAR | Paccar Inc | Bolgar Paulo Henrique | VP | S - Sale+OE | $122.43 | -12,183 | 7,048 | -63% | -$1,491,524 | |||||
| D | 2026-02-02 | PCAR | Paccar Inc | Poplawski Brice J | SVP, CFO | S - Sale+OE | $123.99 | -2,200 | 19,096 | -10% | -$272,778 | |||||
| D | 2026-02-02 | PCAR | Paccar Inc | Bloch Laura J | SVP | S - Sale+OE | $123.57 | -6,588 | 8,447 | -44% | -$814,088 | |||||
| D | 2026-01-29 | LIFE | Ethos Technologies Inc. | Botha Roelof | Dir, 10% | P - Purchase | $19.00 | +260,525 | 260,525 | New | +$4,949,975 | |||||
2026-01-29 | SPMC | Sound Point Meridian Capital, Inc. | Assured Guaranty Ltd | 10% | S - Sale | $14.32 | -237 | 5,269,453 | 0% | -$3,393 | ||||||
| D | 2026-02-02 | AXSM | Axsome Therapeutics, Inc. | Tabuteau Herriot | CEO, 10% | S - Sale+OE | $185.60 | -32,410 | 7,351,729 | 0% | -$6,015,296 | |||||
2026-01-29 | SHCO | Soho House & Co Inc. | Goldman Sachs Group Inc | 10% | S - Sale | $9.00 | -1,666,666 | 13,859,953 | -11% | -$14,999,994 | ||||||
2026-01-29 | SHCO | Soho House & Co Inc. | Goldman Sachs Group Inc | 10% | S - Sale | $9.00 | -1,666,666 | 13,859,953 | -11% | -$14,999,994 | ||||||
2026-01-29 | CATY | Cathay General Bancorp | Lo Thomas M. | EVP, Chief Admin Officer | S - Sale | $50.23 | -1,000 | 2,000 | -33% | -$50,232 | ||||||
| D | 2026-01-29 | KEY | Keycorp /New/ | Mago Angela G | CHRO | S - Sale+OE | $21.55 | -62,850 | 261,415 | -19% | -$1,354,418 | |||||
| D | 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | S - Sale+OE | $7.45 | -16,667 | 1,243,174 | -1% | -$124,147 | |||||
2026-02-02 | EPR | Epr Properties | Zimmerman Gregory E | EVP, Chief Investment Officer | S - Sale | $53.89 | -7,500 | 66,294 | -10% | -$404,192 | ||||||
| D | 2026-01-29 | FHN | First Horizon Corp | Restel Anthony J | SEVP, Chief Banking Officer | S - Sale+OE | $24.35 | -5,719 | 642,031 | -1% | -$139,237 | |||||
| M | 2026-01-30 | ADX | Adams Diversified Equity Fund, Inc. | Kerns Janis F. | Gen. Counsel, Corp. Secretary | P - Purchase | $23.23 | +321 | 51,990 | +1% | +$7,458 | |||||
| D | 2026-01-29 | FHN | First Horizon Corp | Jordan D Bryan | COB, Pres, CEO | S - Sale+OE | $24.16 | -85,009 | 2,082,984 | -4% | -$2,054,164 | |||||
2026-01-30 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $119.15 | -7,665 | 314,265 | -2% | -$913,312 | ||||||
2026-01-30 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $119.15 | -7,665 | 314,265 | -2% | -$913,311 | ||||||
2026-01-30 | IP | International Paper Co /New/ | Connor Christopher M | Dir | P - Purchase | $40.37 | +25,000 | 25,000 | New | +$1,009,250 | ||||||
2026-01-29 | DVA | Davita Inc. | Berkshire Hathaway Inc | 10% | S - Sale | $120.56 | -1,658,480 | 30,100,585 | -5% | -$199,939,881 | ||||||
2026-02-02 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | CEO | P - Purchase | $1.68 | +2,900 | 548,331 | +1% | +$4,872 | ||||||
| D | 2026-01-30 | QCRH | Qcr Holdings Inc | Gipple Todd A | Pres, CFO | S - Sale+OE | $89.92 | -8,590 | 60,238 | -12% | -$772,437 | |||||
| D | 2026-01-30 | ZVRA | Zevra Therapeutics, Inc. | Sangiovanni Timothy J. | SVP, Finance, Corp Controller | S - Sale+OE | $8.82 | -1,750 | 32,590 | -5% | -$15,442 | |||||
| D | 2026-01-30 | ZVRA | Zevra Therapeutics, Inc. | Thompson Rahsaan | Chief Legal, Compliance | S - Sale+OE | $8.83 | -4,080 | 49,919 | -8% | -$36,010 | |||||
| D | 2026-01-30 | ZVRA | Zevra Therapeutics, Inc. | Quartel Adrian W | Chief Medical Officer | S - Sale+OE | $8.83 | -4,533 | 9,723 | -32% | -$40,036 | |||||
| D | 2026-01-30 | ZVRA | Zevra Therapeutics, Inc. | Schafer Joshua | CCO | S - Sale+OE | $8.83 | -3,375 | 72,778 | -4% | -$29,800 | |||||
| D | 2026-02-02 | ZVRA | Zevra Therapeutics, Inc. | McFarlane Neil F. | Pres, CEO | S - Sale+OE | $9.38 | -91,000 | 364,350 | -20% | -$853,425 | |||||
2025-11-05 | SGU | Star Group, L.P. | Hammond Jeffrey S | COO | P - Purchase | $11.99 | +105 | 6,903 | +2% | +$1,257 | ||||||
| D | 2026-02-02 | LIND | Lindblad Expeditions Holdings, Inc. | Bressler Benjamin | *Founder, CEO of NHA | S - Sale+OE | $17.08 | -87,478 | 23,466 | -79% | -$1,494,203 | |||||
2026-01-29 | NPWR | Net Power Inc. | Npeh, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
| M | 2026-01-29 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $4.23 | -24,770 | 555,559 | -4% | -$104,862 | |||||
| DM | 2026-01-29 | UWMC | Uwm Holdings Corp | Mat Ishbia | Pres, CEO, 10% | S - Sale+OE | $5.32 | -1,898,622 | 7,136,632 | -21% | -$10,100,669 | |||||
2026-01-29 | NPWR | Net Power Inc. | 8 Rivers Capital, LLC | 10% | S - Sale | $2.35 | -54,780 | 1,200,000 | -4% | -$128,651 | ||||||
| M | 2026-01-29 | LIND | Lindblad Expeditions Holdings, Inc. | Lindblad Sven-Olof | Dir, 10% | S - Sale | $16.76 | -183,639 | 11,172,779 | -2% | -$3,078,396 | |||||
2026-02-02 | URI | United Rentals, Inc. | Durand Michael D | EVP, COO | S - Sale | $791.14 | -2,490 | 7,458 | -25% | -$1,969,946 | ||||||
| M | 2026-01-15 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $1.62 | -61,194 | 1,139,177 | -5% | -$99,331 | |||||
2026-01-30 | ELUT | Elutia Inc. | Rakin Kevin | Dir, 10% | P - Purchase | $1.06 | +70,000 | 5,225,098 | +1% | +$74,200 | ||||||
2026-01-30 | RPRX | Royalty Pharma Plc | Urist Marshall | EVP, Research, Investments | S - Sale | $41.09 | -20,000 | 26,418 | -43% | -$821,810 | ||||||
2026-01-29 | UNTY | Unity Bancorp Inc /Nj/ | Donovan James Joseph | Chief Lending Officer, FSVP | S - Sale | $52.11 | -265 | 5,200 | -5% | -$13,809 | ||||||
| D | 2026-02-02 | FENC | Fennec Pharmaceuticals Inc. | Raykov Rosty | Dir | S - Sale+OE | $7.76 | -10,349 | 98,477 | -10% | -$80,308 | |||||
2026-01-29 | CR | Crane Co | Pollino Jennifer | Dir | P - Purchase | $184.29 | +1,500 | 1,500 | New | +$276,435 | ||||||
2026-01-29 | EAT | Brinker International, Inc | Hochman Kevin | Pres, CEO | S - Sale | $160.31 | -66,000 | 129,824 | -34% | -$10,580,460 | ||||||
2026-02-02 | XASIX | Carlyle Alpinvest Private Markets Secondaries Fund | O'Connor Joseph A. | Officer of the Adviser | P - Purchase | $10.38 | +723 | 26,146 | +3% | +$7,501 | ||||||
2026-01-29 | CR | Crane Co | Lynch Susan D | Dir | P - Purchase | $182.22 | +150 | 220 | +214% | +$27,334 | ||||||
2026-01-29 | EAT | Brinker International, Inc | Edelman Harriet | Dir | S - Sale | $159.00 | -8,400 | 21,004 | -29% | -$1,335,600 | ||||||
2026-01-29 | CR | Crane Co | Kapoor Sanjay | Dir | P - Purchase | $177.68 | +2,814 | 2,814 | New | +$499,992 | ||||||
2026-01-30 | CR | Crane Co | Mitchell Max H | COB, Pres, CEO | P - Purchase | $183.71 | +1,000 | 413,638 | 0% | +$183,710 | ||||||
2026-01-30 | ATLO | Ames National Corp | Cassabaum Michelle R | Dir | P - Purchase | $26.11 | +280 | 9,193 | +3% | +$7,311 | ||||||
| D | 2026-02-02 | CYTK | Cytokinetics Inc | Callos Andrew | EVP, Chief Commercial Officer | S - Sale+OE | $62.10 | -886 | 50,440 | -2% | -$55,021 | |||||
| M | 2026-01-26 | NEOG | Neogen Corp | Nassif Mikheal | CEO | P - Purchase | $9.93 | +49 | 681 | +8% | +$486 | |||||
| D | 2026-01-29 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $93.99 | -317 | 9,168 | -3% | -$29,794 | |||||
2026-01-29 | CNXC | Concentrix Corp | Caldwell Christopher A | Pres, CEO | P - Purchase | $37.07 | +1,000 | 362,075 | 0% | +$37,070 | ||||||
| D | 2026-01-29 | NUVL | Nuvalent, Inc. | Noci Darlene | Chief Development Officer | S - Sale+OE | $102.08 | -5,500 | 58,117 | -9% | -$561,422 | |||||
| D | 2026-01-29 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $94.00 | -1,653 | 16,458 | -9% | -$155,375 | |||||
2026-01-29 | DBVT | Dbv Technologies S.A. | Mohideen Pharis | Chief Medical Officer | S - Sale | $4.86 | -534 | 144,995 | 0% | -$2,595 | ||||||
| D | 2026-01-29 | CXM | Sprinklr, Inc. | Thomas Ragy | Dir | S - Sale+OE | $6.35 | -1,054 | 712,349 | 0% | -$6,693 | |||||
2026-02-02 | ABEO | Abeona Therapeutics Inc. | Alland Leila | Dir | S - Sale | $5.09 | -18,065 | 173,614 | -9% | -$91,962 | ||||||
2026-02-02 | ABEO | Abeona Therapeutics Inc. | Alvino Mark | Dir | S - Sale | $5.09 | -2,000 | 84,065 | -2% | -$10,181 | ||||||
| D | 2026-01-29 | SF | Stifel Financial Corp | Zemlyak James M | Pres | S - Sale+OE | $123.90 | -9 | 1,160,626 | 0% | -$1,115 | |||||
2026-01-29 | CRDO | Credo Technology Group Holding Ltd | Cheng Chi Fung | CTO | S - Sale | $127.37 | -27,500 | 6,411,090 | 0% | -$3,502,660 | ||||||
| D | 2026-01-29 | MAZE | Maze Therapeutics, Inc. | Dandekar Atul | CSBO | S - Sale+OE | $44.27 | -7,500 | 10,503 | -42% | -$331,990 | |||||
2026-01-29 | CRDO | Credo Technology Group Holding Ltd | Brennan William Joseph | Pres, CEO | S - Sale | $127.69 | -68,016 | 2,085,127 | -3% | -$8,684,909 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |